Name | Walgreens #10603 |
---|---|
Organization Name | Walgreen Co |
Location | 3475 E 17th St, Ammon, Idaho 83406 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (208) 227-5083 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Baseline serum interferon-inducible protein 10 levels predict hepatitis B surface antigen reduction in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection treated with tenofovir disoproxil fumarate, findings indicate.
Researchers from the Harvard School of Public Health and the Karolinska Institute in Stockholm, Sweden, have found no association between acrylamide intake in foods and risk of breast cancer among Swedish women. The findings appear in the March 16, 2005 issue of the Journal of the American Medical Association.
CivaTech Oncology, an RTP medical device company dedicated to developing novel radiation therapy devices, announced the award of a $1M Phase II Contract from the National Institutes of Health and the National Cancer Institute to further develop and commercialize CivaSheet, a bioabsorbable uni-directional device for treatment of non-small-cell lung cancer.
Researchers from Boston University School of Medicine (BUSM), Boston University School of Public Health (BUSPH), and the National Heart, Lung and Blood Institute (NHLBI), have completed analyses of a genome-wide scan on a group of two generations of participants from the landmark Framingham Heart Study (FHS).
› Verified 9 days ago
NPI Number | 1811030950 |
Organization Name | WALGREEN CO |
Doing Business As | WALGREENS #10603 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 3475 E 17th St, Ammon, ID 83406 |
Phone Number | 208-227-5083 |
News Archive
Baseline serum interferon-inducible protein 10 levels predict hepatitis B surface antigen reduction in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection treated with tenofovir disoproxil fumarate, findings indicate.
Researchers from the Harvard School of Public Health and the Karolinska Institute in Stockholm, Sweden, have found no association between acrylamide intake in foods and risk of breast cancer among Swedish women. The findings appear in the March 16, 2005 issue of the Journal of the American Medical Association.
CivaTech Oncology, an RTP medical device company dedicated to developing novel radiation therapy devices, announced the award of a $1M Phase II Contract from the National Institutes of Health and the National Cancer Institute to further develop and commercialize CivaSheet, a bioabsorbable uni-directional device for treatment of non-small-cell lung cancer.
Researchers from Boston University School of Medicine (BUSM), Boston University School of Public Health (BUSPH), and the National Heart, Lung and Blood Institute (NHLBI), have completed analyses of a genome-wide scan on a group of two generations of participants from the landmark Framingham Heart Study (FHS).
› Verified 9 days ago
News Archive
Baseline serum interferon-inducible protein 10 levels predict hepatitis B surface antigen reduction in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection treated with tenofovir disoproxil fumarate, findings indicate.
Researchers from the Harvard School of Public Health and the Karolinska Institute in Stockholm, Sweden, have found no association between acrylamide intake in foods and risk of breast cancer among Swedish women. The findings appear in the March 16, 2005 issue of the Journal of the American Medical Association.
CivaTech Oncology, an RTP medical device company dedicated to developing novel radiation therapy devices, announced the award of a $1M Phase II Contract from the National Institutes of Health and the National Cancer Institute to further develop and commercialize CivaSheet, a bioabsorbable uni-directional device for treatment of non-small-cell lung cancer.
Researchers from Boston University School of Medicine (BUSM), Boston University School of Public Health (BUSPH), and the National Heart, Lung and Blood Institute (NHLBI), have completed analyses of a genome-wide scan on a group of two generations of participants from the landmark Framingham Heart Study (FHS).
› Verified 9 days ago
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3135 E 17th St, Ammon, Idaho 83406 Phone: (208) 524-4211 | |
Wal-mart Pharm 10-1902 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1201 S 25th E, Ammon, Idaho 83406 Phone: (208) 522-2866 | |
Sav-on Pharmacy #3174 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1901 S 25th E, Ammon, Idaho 83406 Phone: (208) 524-1616 | |
Heartland Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3250 E 17th St, Ammon, Idaho 83406 Phone: (208) 552-7677 | |
Walgreens #10603 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3475 E 17th St, Ammon, Idaho 83406 Phone: (208) 227-5083 |